本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

13.60
-0.1700-1.23%
盘后13.600.00000.00%16:05 EDT
成交量:61.07万
成交额:826.34万
市值:6.76亿
市盈率:-3.65
高:13.91
开:13.89
低:13.28
收:13.77
数据加载中...
2023/03/09

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/31

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/01/05

重要事件披露

8-K - Current report
2022/12/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/27

重要事件披露

8-K - Current report
2022/12/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/12/08

重要事件披露

8-K - Current report
2022/10/17

重要事件披露

8-K - Current report
2022/09/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/08

重要事件披露

8-K - Current report
2022/08/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals